Fungal infections are on the rise globally. According to a study by the Manchester Fungal Infection Group, in 2022, ...

Dr. Khandros will remain on the board of directors of Nutcracker Therapeutics, and Cynthia Collins will serve as executive ...

Primrose Bio, Inc. ("Primrose"), a company developing proprietary therapeutic manufacturing technologies, announces the ...

Avidity Biosciences, Inc.'s innovative AOC platform and promising clinical programs make it a high-risk, high-reward ...

Researchers at University of Tsukuba have developed "tomoseqr"—a new software tool that enables easy estimation of the ...

Gannon University and Saint Vincent Hospital announced plans Wednesday to develop two new laboratories inside Gannon's ...

Scientists have made a major breakthrough in the accuracy and speed at which often deadly pathogen infections can be ...

R&D Expenses: Research and development expenses for the year ended December 31, 2024 decreased to approximately $2,044,000 ...

Brisbane’s property market could overtake Sydney as the most expensive in Australia by 2032, with experts predicting massive ...

Theratechnologies Inc.’s THTX share price has surged by 28.57%, which has investors questioning if this is right time to sell ...

Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the “Company”), a leader in PCR-based DNA technologies, today announced that Applied DNA Clinical Labs (ADCL), the Company’s wholly-owned ...

Multiple suburbs are on a fast track that could see as much as a doubling in home prices off billions being spent on Olympic ...